These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8572653)
1. Immunostimulation by propionibacteria--effects on immune status and antineoplastic treatment. Isenberg J; Stoffel B; Wolters U; Beuth J; Stützer H; Ko HL; Pichlmaier H Anticancer Res; 1995; 15(5B):2363-8. PubMed ID: 8572653 [TBL] [Abstract][Full Text] [Related]
2. Preoperative immunostimulation by Propionibacterium granulosum KP-45 in colorectal cancer. Isenberg J; Ko H; Pulverer G; Grundmann R; Stützer H; Pichlmaier H Anticancer Res; 1994; 14(3B):1399-404. PubMed ID: 8067712 [TBL] [Abstract][Full Text] [Related]
3. [Neopterin as a marker of aspecific immunostimulation with Propionibacterium avidum KP-40 in patients with gastrointestinal tumors. A prospective randomized study]. Peters KM; Bornhofen B; Grundmann R; Ko HL; Beuth J; Waters W; Pichlmaier H; Pulverer G Med Klin (Munich); 1990 Jul; 85(7):421-4. PubMed ID: 2385207 [TBL] [Abstract][Full Text] [Related]
4. Influence of propionibacterium avidum KP-40 on the proliferation, maturation, emigration and activity of thymocytes and monocytes. Ko HL; Winkler C; Beuth J; Tunggal L; Buss G; Jeljaszewicz J; Klippel KF; Pulverer G Zentralbl Bakteriol; 1995 Jan; 282(1):86-91. PubMed ID: 7734834 [TBL] [Abstract][Full Text] [Related]
5. [Preoperative nonspecific immunostimulation with Propionibacterium granulosum KP-45 in patients with colorectal cancer. A prospective randomized study]. Grundmann R; Weber F; Kluger J; Wienand P; Pulverer G Chirurg; 1988 Apr; 59(4):272-8. PubMed ID: 3289850 [TBL] [Abstract][Full Text] [Related]
7. Behaviour of lymphocyte subsets in response to immunotherapy with Propionibacterium avidum KP-40 in cancer patients. Beuth J; Ko HL; Peters KM; Bornhofen B; Pulverer G Zentralbl Bakteriol; 1990 Aug; 273(3):386-90. PubMed ID: 2206205 [TBL] [Abstract][Full Text] [Related]
8. Comparative study on lymphocyte subpopulations in cancer patients after immunostimulation with propionibacteria and in renal transplant patients after combined immunosuppression. Peters KM; Pfeiffer R; Bornhofen B; Ko HL; Beuth J; Grundmann R; Pulverer G Arzneimittelforschung; 1990 Oct; 40(10):1162-6. PubMed ID: 2149816 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of chronic active viral hepatitis B with propionibacterium granulosum. Gil J; Ziemka J; Brzosko WJ; Dabrowski M; Dabrowska-Bernstein B; Szmigielski S; Ko HL; Jeljaszewicz J; Pulverer G Hepatogastroenterology; 1984 Jun; 31(3):109-18. PubMed ID: 6205967 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic lymphocytes in rat tumor in situ: effect of intraperitoneal injections of Propionibacterium avidum. Hojo H; Endoh YS; Hashimoto Y Jpn J Cancer Res; 1985 Jan; 76(1):53-60. PubMed ID: 3918910 [TBL] [Abstract][Full Text] [Related]
11. Application-dependent immunomodulating and antimetastatic efficacy of thymic peptides in BALB/c-mice. Beuth J; Schierholz JM; Ko HL; Braun JM In Vivo; 2001; 15(5):403-6. PubMed ID: 11695237 [TBL] [Abstract][Full Text] [Related]
12. Preoperative immunostimulation with propionibacterium avidum KP-40 in patients with gastric carcinoma: a prospective randomized study. Peters KM; Beuth J; Ko HL; Pulverer G; Kluger J; Grundmann R Onkologie; 1990 Apr; 13(2):124-7. PubMed ID: 2197583 [TBL] [Abstract][Full Text] [Related]
13. Combined immunostimulation (Propionibacterium avidum KP 40) and anticoagulation (heparin) prevents metastatic lung and liver colonization in mice. Beuth J; Ko HL; Uhlenbruck G; Pulverer G J Cancer Res Clin Oncol; 1987; 113(4):359-62. PubMed ID: 3597521 [TBL] [Abstract][Full Text] [Related]
14. [Enhancement of antitumor activity of Propionibacterium avidum in combined with neurotropin in tumor bearing mice]. Toge T; Nakane H; Tanada M; Seto Y; Hamamoto S; Itagaki E; Tomoda S; Hattori T Gan To Kagaku Ryoho; 1983 Nov; 10(11):2389-92. PubMed ID: 6227292 [TBL] [Abstract][Full Text] [Related]
15. Immunostimulation by systemic administration of Propionibacterium granulosum in patients with primary or secondary lung tumours. Roszkowski K; Gil J; Roszkowski W; Szmigielski S; Nowakowski W; Ko HL; Pulverer G; Jeljaszewicz J Eur J Respir Dis; 1981 Dec; 62(6):425-33. PubMed ID: 7347693 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of immune responses to suramin correlates with antineoplastic activity in BALB/c-mice. Ko HL; Beuth J; Tunggal L; Gil M; Jeljaszewicz J; Pulverer G In Vivo; 1994; 8(2):173-6. PubMed ID: 7919119 [TBL] [Abstract][Full Text] [Related]
17. Murine thymocyte proliferation, maturation and emigration in response to selenium. Stoffel B; Krämer K; Beuth J Arzneimittelforschung; 1996 Aug; 46(8):829-31. PubMed ID: 9125288 [TBL] [Abstract][Full Text] [Related]
18. Effect of three strains of propionibacteria (P. granulosum, P. avidum, P. acnes) and cell-wall preparations on lymphocytes and macrophages. Roszkowski W; Szmigielski S; Ko HL; Janiak M; Wrembel JK; Pulverer G; Jeljaszewicz J Zentralbl Bakteriol A; 1980 Mar; 246(3):393-404. PubMed ID: 7424239 [TBL] [Abstract][Full Text] [Related]
19. Action of three species of Propionibacteria (P. granulosum, P. acnes, P. avidum) on experimental tumor systems in mice. Roszkowski W; Kobus M; Luczak M; Ko HL; Szmigielski S; Laskowska B; Pulverer G; Jeljaszewicz J Zentralbl Bakteriol A; 1980 Mar; 246(3):405-14. PubMed ID: 6252722 [TBL] [Abstract][Full Text] [Related]